CDT
CDT Equity Inc.·Healthcare
4.08
30.730%(−1.81)
Market ClosedLast Updated: — ET
52W L: $3.6452W H: $3030.00
CDT NEWS
businesswire.com
1d ago
Rosen Law Firm Encourages CDT Environmental Technology Investment Holdings Ltd. Investors to Inquire About Securities Class Action Investigation – CDTG
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of CDT Environmental Technology Investment Holdings Ltd. (NASDAQ: CDTG) resulting from allegations that CDT Environmental may have issued materially misleading business information to the investing public. So what: If you purchased CDT Environmental securities you may be entitled to compensation without payment of any out of pocke.
businesswire.com
2d ago
Rosen Law Firm Encourages CDT Environmental Technology Investment Holdings Ltd. Investors to Inquire About Securities Class Action Investigation – CDTG
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of CDT Environmental Technology Investment Holdings Ltd. (NASDAQ: CDTG) resulting from allegations that CDT Environmental may have issued materially misleading business information to the investing public. So what: If you purchased CDT Environmental securities you may be entitled to compensation without payment of any out of pocke.
globenewswire.com
4d ago
CDT Notes Sarborg Publication of PRISM Framework Expanding AI
NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 07, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding the publication of its research paper titled “PRISM: cross-species connectivity mapping of plant intervention and stress signatures for translational agriculture.
defenseworld.net
Mar 31
CDT Equity Inc. (NASDAQ:CDT) Sees Significant Decrease in Short Interest
CDT Equity Inc. (NASDAQ: CDT - Get Free Report) was the target of a large decrease in short interest in the month of March. As of March 13th, there was short interest totaling 129,934 shares, a decrease of 26.9% from the February 26th total of 177,766 shares. Approximately 6.3% of the company's shares are short sold.
globenewswire.com
Mar 26
CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings
NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 26, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced the filing of two new patent applications that further expand the Company's intellectual property portfolio surrounding tapinarof, a drug currently approved for the treatment of psoriasis and atopic dermatitis.
globenewswire.com
Mar 25
CDT Equity Inc. Announces Reverse Stock Split
NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 25, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) announces that its board of directors has approved a 1-for-25 reverse stock split of the Company's common stock.
